As of Mar 27
| +1.17 / +2.40%|
The 25 analysts offering 12-month price forecasts for Sanofi have a median target of 49.98, with a high estimate of 56.07 and a low estimate of 42.09. The median estimate represents a +0.01% increase from the last price of 49.97.
The current consensus among 28 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.